Human medicines European public assessment report (EPAR): Viread, tenofovir disoproxil, Date of authorisation: 04/02/2002, Revision: 61, Status: Authorised

Human medicines European public assessment report (EPAR): Viread, tenofovir disoproxil, Date of authorisation: 04/02/2002, Revision: 61, Status: Authorised

Human medicines European public assessment report (EPAR): Onbrez Breezhaler, indacaterol, Date of authorisation: 29/11/2009, Revision: 20, Status: Authorised

Human medicines European public assessment report (EPAR): Onbrez Breezhaler, indacaterol, Date of authorisation: 29/11/2009, Revision: 20, Status: Authorised

Medicine shortages: EMA public webinar putting patients first, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 4 November 2025, 14:00 (CET) to 4 November 2025, 16:00 (CET)

Medicine shortages: EMA public webinar putting patients first, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 4 November 2025, 14:00 (CET) to 4 November 2025, 16:00 (CET)

Human medicines European public assessment report (EPAR): Truvada, emtricitabine,tenofovir disoproxil, Date of authorisation: 20/02/2005, Revision: 49, Status: Authorised

Human medicines European public assessment report (EPAR): Truvada, emtricitabine,tenofovir disoproxil, Date of authorisation: 20/02/2005, Revision: 49, Status: Authorised

Fifth Veterinary Big Data Stakeholder Forum, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 10 November 2025, 09:00 (CET) to 10 November 2025, 17:30 (CET)

Fifth Veterinary Big Data Stakeholder Forum, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 10 November 2025, 09:00 (CET) to 10 November 2025, 17:30 (CET)

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.